0001891891-23-000002.txt : 20230525 0001891891-23-000002.hdr.sgml : 20230525 20230524185624 ACCESSION NUMBER: 0001891891-23-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20230525 DATE AS OF CHANGE: 20230524 EFFECTIVENESS DATE: 20230525 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Quanta Therapeutics, Inc. CENTRAL INDEX KEY: 0001891891 IRS NUMBER: 831445023 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-482575 FILM NUMBER: 23955490 BUSINESS ADDRESS: STREET 1: 455 MISSION BAY BLVD. SOUTH RM 322 CITY: SAN FRANCISCO STATE: CA ZIP: 94158 BUSINESS PHONE: (650) 799-8230 MAIL ADDRESS: STREET 1: 455 MISSION BAY BLVD. SOUTH RM 322 CITY: SAN FRANCISCO STATE: CA ZIP: 94158 D 1 primary_doc.xml X0708 D LIVE 0001891891 Quanta Therapeutics, Inc. 2 Tower Place, Floor 17 SAN FRANCISCO CA CALIFORNIA 94080 (650) 799-8230 DELAWARE None None Corporation true 2018 Perry Nisen 2 Tower Place, Floor 17 San Francisco CA CALIFORNIA 94080 Executive Officer Director Maria Fardis 2 Tower Place, Floor 17 San Francisco CA CALIFORNIA 94080 Director Arjun Goyal 2 Tower Place, Floor 17 San Francisco CA CALIFORNIA 94080 Director Maha Katabi 2 Tower Place, Floor 17 San Francisco CA CALIFORNIA 94080 Director Cameron Pitt 2 Tower Place, Floor 17 San Francisco CA CALIFORNIA 94080 Executive Officer Samuel Saks 2 Tower Place, Floor 17 San Francisco CA CALIFORNIA 94080 Director Ying Huang 2 Tower Place, Floor 17 San Francisco CA CALIFORNIA 94080 Director Leonardo Faoro 2 Tower Place, Floor 17 San Francisco CA CALIFORNIA 94080 Executive Officer Biotechnology Decline to Disclose 06b false 2023-05-10 false true false 0 54999988 50685368 4314620 false 13 0 0 0 false Quanta Therapeutics, Inc. /s/ Perry Nisen Perry Nisen CEO 2023-05-24